With more than 6,000 scientists, physicians and business professionals around the world, Novartis Institutes for BioMedical Reseach is focused on discovering and developing innovative new medicines to cure disease and improve human health. NIBR is redefining the way we understand and treat disease that will change the practice of medicine. As part of its drug discovery mission, the Genomics Institute of the Novartis Research Foundation develops innovative technology that makes possible new approaches to complex biomedical problems in core areas such as Cancer Biology, Infectious Disease, Immunology and Metabolic/Cardiovascular Disease.
"[The Novartis] workflow system uses Hadoop for performance and robustness and MapR to provide the POSIX file access that lets bioinformaticians use their familiar tools. Additionally, it uses the researchers’ own metadata to allow them to write complex workflows that blend the best aspects of Hadoop and traditional HPC."
- David Tester, Application Architect for Novartis Institutes for Biomedical Research
Creating Flexible Big Data Solutions for Drug Discovery
Novartis Relies on MapR for Flexible Big Data Solutions for Drug Discovery